Previous 10 | Next 10 |
2023-10-26 13:36:09 ET More on ABVC BioPharma ABVC looks to establish a healthcare center, buys 20% stake in real estate property ABVC stock rallies on Chinese licensing deal for psych drugs Financial information for ABVC BioPharma For further details see: ...
2023-10-26 09:56:15 ET DENVER, Colo., Oct. 26, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ABVC BioPharma Inc (NASDAQ: ABVC), PaxMedica Inc (NASDAQ: PXMD), TransCode Therapeutics Inc (NASDAQ: RNAZ), M...
2023-10-26 09:02:11 ET DENVER, Colo., Oct 26, 2023 ( www.247marketnews.com )- ABVC BioPharma, Inc. (NASDAQ: ABVC) stated this morning, that it entered into a binding term sheet regarding a multi-year, global licensing agreement with AiBtl BioPharma for the Company’s CNS drugs wit...
FREMONT, CA - ( NewMediaWire ) - October 26, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that it...
FREMONT, CA - ( NewMediaWire ) - October 17, 2023 - ABVC BioPharma, Inc . (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced an update on the Company's eight-week ...
The Company Holds a US Patent for the Same Treatment FREMONT, CA - ( NewMediaWire ) - October 09, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hemato...
FREMONT, CA - ( NewMediaWire ) - August 23, 2023 - ABVC BioPharma, Inc . (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that 60 subjects had been enrolled and 53 had co...
2023-08-22 10:00:48 ET Gainers: Fulcrum Therapeutics ( FULC ) +55% . Renovaro Biosciences ( RENB ) +18% . ProMIS Neurosciences ( PMN ) +17% . cbdMD ( YCBD ) +9% . 60 Degrees Pharmaceuticals ( SXTP ) +7% . Losers: Emergent BioSo...
2023-08-17 13:26:45 ET More on ABVC BioPharma ABVC stock rallies on Chinese licensing deal for psych drugs Thailand FDA approves ABVC BioPharma's phase 2 study plan for its eye-gel substitute ABVC Biopharma stock rises on upcoming US patent for ABV-1504 to treat depres...
FREMONT, CA - ( NewMediaWire ) - August 17, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it had entered into a Cooperation Agr...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- After successfully completing Phase II clinical trials for their medication to treat Major Depressive Disorder, ABVC BioPharma Inc. and AiBtl BioPharma Inc. are now embarking on a groundbreaking clinical study focused on Depression in Cancer Patients. This new study will i...
FREMONT, CA - ( NewMediaWire ) - July 9, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that after successful Phase II c...
FREMONT, CA - ( NewMediaWire ) - July 02, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and it...